Synthorx (Series A)

Funding Details
Awarder
Inbox
Date Award
July 20, 2016
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$10,000,000

Company Info
Founding Year
2014
Founders
Floyd Romesberg
Company Description
Synthorx is a biotechnology company using synthetic biology to synthesize solutions for the discovery and development of novel therapeutics, diagnostics and vaccines. With the revolutionary advancement of synthetic nucleotides that can be maintained and replicated by a single-cell organism, Synthorx is exploring the natural and evolution-directed technologies to improve drug discovery.
Market
Therapeutics, Diagnostics, and Vaccines
Location
La Jolla, California, USA
Coinvestors
Correlation Ventures, RA Capital Management

Links